United Kingdom Veterinary Healthcare Market Size, Share, and COVID-19 Impact Analysis, By Product (Therapeutics, Diagnostics, and Other Products) and Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animal Types), and United Kingdom Veterinary Healthcare Market Insights, Industry Trend, Forecasts to 2033

United Kingdom Veterinary Healthcare Market Insights Forecasts to 2033

• The U.K. Veterinary Healthcare Market Size was valued at USD 1.64 Billion in 2023.
• The U.K. Veterinary Healthcare Market is growing at a CAGR of 6.91% from 2023 to 2033
• The U.K. Veterinary Healthcare Market Size is expected to reach USD 3.20 Billion by 2033

The United Kingdom Veterinary Healthcare Market is anticipated to exceed USD 3.20 Billion by 2033, growing at a CAGR of 6.91% from 2023 to 2033. The growing technological advancements & innovation in animal healthcare, growing pet ownership, and growing productivity at the risk of emerging zoonosis are driving the growth of the veterinary healthcare market in the UK.     

Market Overview

The veterinary healthcare market is the industry comprising of diagnosis, treatment, and prevention of diseases in animals. It includes products and services like veterinary pharmaceuticals, vaccines, diagnostics, and equipment, as well as various veterinary services. Veterinary healthcare refers to the medical treatment and preventative measures provided to animals by a veterinarian, which includes diagnosing illnesses, administrating treatments, and ensuring the overall well-being of the animal. Advanced technology and increasing pet ownership, particularly in the molecular diagnostics and vaccines segments, are driving the market growth. The continuous innovations and the development of genetically engineered vaccines for boosting animal immunity are further driving the market development. In addition, the growth in the specialized veterinary services in the fields of oncology, cardiology, neurology, and dermatology are providing market growth opportunities. 

Report Coverage

This research report categorizes the market for the UK veterinary healthcare market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom veterinary healthcare market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the UK veterinary healthcare market.

Driving Factors

The growing technological advancements & innovation in animal healthcare, including the monitoring technologies that enable real-time monitoring of health by tracking vital signs like temperature, activity levels, feeding rates, etc., are propelling the market growth. The increasing pet ownership, especially during the period of the pandemic, resulted in driving the market growth. The emergence and spread of zoonotic diseases along with the growing awareness about animal health are also responsible for driving the market demand. In addition, technological advancements in animal healthcare diagnostics and government initiatives are contributing to driving the market growth.

Restraining Factors

The use of counterfeit medicines and growing pet care costs are challenging the veterinary healthcare market.

Market Segmentation

The United Kingdom veterinary healthcare market share is classified into product and animal type. 

• The therapeutics segment dominated the market with the largest market share in 2023 and is expected to grow at a significant CAGR during the projected period.

The United Kingdom veterinary healthcare market is segmented by product into therapeutics, diagnostics, and other products. Among these, the therapeutics segment dominated the market with the largest market share in 2023 and is expected to grow at a significant CAGR during the projected period. The segment includes drugs, vaccines, and feed additives for improving animal health. The need for animals, ensuring well-being, productivity, and public health by preventing zoonotic diseases, is driving the market demand in the therapeutics segment.

• The dogs and cats segment dominated the veterinary healthcare market and is expected to grow at a significant CAGR during the projected period.

The United Kingdom veterinary healthcare market is segmented by animal type into dogs and cats, horses, ruminants, swine, poultry, and other animal types. Among these, the dogs and cats segment dominated the veterinary healthcare market and is expected to grow at a significant CAGR during the projected period. Various types of diseases in animals have led to drive the demand for vaccines and diagnostic tests, which ultimately surges the demand for curing and treating diseases. The increasing pet ownership of dogs and cats is driving the market demand in the dogs and cats segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the U.K. veterinary healthcare market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Boehringer Ingelheim International GmbH
• Ceva Animal Health Inc.
• Covetrus Inc.
• ECO Animal Health Ltd
• Elanco
• KRKA UK Ltd
• MSD Animal Health
• TVM UK
• Vetoquinol UK Limited
• Virbac Corporation
• Zoetis Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In February 2024, ECO Animal Health Group plc, a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announced that the ECOVAXXIN trademark has been approved by the European Union ("EU").

• In January 2024, Antech, the veterinary diagnostics company focused on helping veterinary professionals predict, diagnose, and monitor wellness and disease, announced it would launch the breakthrough in-hospital Nu.Q Canine Cancer Test at this year’s annual VMX meeting.

Market Segment

This study forecasts revenue at U.K., regional, and country levels from 2020 to 2033. Spherical Insights has segmented the United Kingdom Veterinary Healthcare Market based on the below-mentioned segments:

UK Veterinary Healthcare Market, By Product

• Therapeutics
• Diagnostics
• Other Products

UK Veterinary Healthcare Market, By Animal Type

• Dogs and Cats
• Horses
• Ruminants
• Swine
• Poultry
• Other Animal Types